AgeX Therapeutics to Participate at Four Conferences in January 2020
AgeX Therapeutics, Inc. (AGE)
Company Research
Source: Business Wire
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that the company will present at the following four conferences this month: Biotech Showcase, January 13-15; Precision Medicine World Conference (PMWC 2020), January 21-24; World Stem Cell Summit, January 21-24; and Longevity Therapeutics, January 28-30.Details of the company’s presentations follow:Biotech ShowcaseJanuary 13-15 at the Hilton San Francisco Union Square, San Francisco, CaliforniaAgeX session: Wednesday, January 15, 9:00am PST.AgeX’s founder and CEO Michael D. West, PhD will deliver a presentation on AgeX and its programs at this investor conference held concurrently with the J.P. Morgan Healthcare Conference.World Stem Cell SummitJanuary 21-24 at the Hyatt Regency Miami, Miami, Florida.AgeX will participate in a 90-minute session that will include two talks as well as a pa
Show less
Read more
Impact Snapshot
Event Time:
AGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGE alerts
High impacting AgeX Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AGE
News
- Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics [Yahoo! Finance]Yahoo! Finance
- AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsGlobeNewswire
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXXPR Newswire
- AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGEBusiness Wire
AGE
Sec Filings
- 3/26/24 - Form SC
- 3/22/24 - Form 10-K
- 3/22/24 - Form 8-K
- AGE's page on the SEC website